Welcome to BlogNotions' Life Sciences Blog

The BlogNotions Life Sciences Blog delivers a diverse series of perspectives provided by thought leaders in the life sciences industries. Presented by NetLine, this forum delivers compelling updates on the latest technological advances, discussions of research and findings, best practices for advancing education, implications for the future of various life sciences fields, and much more. Here you can find helpful information, ask questions, and collaborate freely.

FDA Approves Osmolex ER (amantadine) for the treatment of Parkinson’s Disease and Drug-Induced Extrapyramidal Reactions

  In continuation of my update on amantadine Osmotica Pharmaceutical US LLC, announced the  U.S. Food and Drug Administration (FDA) has approval Osmolex ER, an amantadine extended release tablet, for the treatment of Parkinson’s disease and for the treatment of drug-induced extrapyramidal reactions in adult patients. Extrapyramidal symptoms are known side effects of many common […]

Continue Reading

Drugs and Devices: Comparison of European and U.S. Approval Processes

This paper was originally published by Gail A.Van Norman, MD, in JACC: Basic to Translational Science Volume 1, Issue 5, August 2016, Pages 399-412 under a Creative Commons license. Summary The… The post Drugs and Devices: Comparison of European and U.S. Approval Processes appeared first on DrugPatentWatch. The post Drugs and Devices: Comparison of European and […]

Continue Reading

New class of antimicrobial polymers can kill five hard-to-treat multidrug-resistant bacteria

An international research team led by the Institute of Bioengineering and Nanotechnology (IBN) of the Agency for Science, Technology and Research (A*STAR) and IBM Research developed a synthetic molecule that can kill five deadly types of multidrug-resistant bacteria with limited, if any, side effects. Their new material could be developed into an antimicrobial drug to […]

Continue Reading

8 Applications of Machine Learning in The Pharmaceutical Industry

By Pankaj Mondal, DrugPatentWatch writer Machine learning, the most fundamental form of artificial intelligence, has started infiltrating the medical field, and it seems machines can play a crucial role in… The post 8 Applications of Machine Learning in The Pharmaceutical Industry appeared first on DrugPatentWatch. The post 8 Applications of Machine Learning in The Pharmaceutical […]

Continue Reading

Antiviral drug not beneficial for reducing mother-to-child transmission of hepatitis B when added to existing preventatives

In continuation of my update on Tenofovir Tenofovir disoproxil fumarate (TDF), an antiviral drug commonly prescribed to treat hepatitis B infection, does not significantly reduce mother-to-child transmission of hepatitis B virus when taken during pregnancy and after delivery, according to a phase III clinical trial in Thailand funded by the National Institutes of Health. The […]

Continue Reading

Compound prevents neurological damage, shows cognitive benefits in mouse model of Alzheimer’s disease

The supplement nicotinamide riboside (NR) – a form of vitamin B3 – prevented neurological damage and improved cognitive and physical function in a new mouse model of Alzheimer’s disease. The results of the study, conducted by researchers at the National Institute on Aging (NIA) part of the National Institutes of Health, suggest a potential new […]

Continue Reading

Aspirin as Good a Clot Buster as Pricey Drugs After Joint Replacement

Good old aspirin is just as effective as newer, expensive drugs at preventing blood clots after hip or knee replacement, a new clinical trial suggests. Researchers said the findings could change some doctors’ prescribing habits. After knee or hip replacement surgery, there’s a risk of blood clots in the legs or lungs. So it’s routine for patients to take […]

Continue Reading

FDA Pushes to Reduce Single-Source Generics, Increase Biosimilars

By Ed Lamb, DrugPatentWatch writer Under a new commissioner dedicated to bolstering competition to reduce prices, the agency is redoing a raft of rules and guidances to speed ANDA approvals… The post FDA Pushes to Reduce Single-Source Generics, Increase Biosimilars appeared first on DrugPatentWatch. The post FDA Pushes to Reduce Single-Source Generics, Increase Biosimilars appeared […]

Continue Reading

Research shows link between fluoroquinolone antibiotics and increased risk of aortic disease

New research from a Swedish and Danish team of researchers led from Karolinska Institutet lend additional support to a link between treatment with fluoroquinolone antibiotics and an increased risk of acute aortic disease. The study is published in the esteemed journal The BMJ. Fluoroquinolone antibiotics are used globally to treat a variety of infections. Recent observational […]

Continue Reading

High vitamin D levels may help prevent cancer

In continuation of my update on Vitamin D,  The study reinforces the existing theory that vitamin D helps defend against certain cancers. Exposure to sunlight stimulates the production of vitamin D by our skin. Vitamin D contributes to calcium level maintenance in our bodies, which in turn helps teeth, muscles and bones remain healthy. Aside from established benefits […]

Continue Reading